Zenotech Laboratories Limited

BOM:532039 ISIN:INE486F01012

2012年5月24日

概览 | 新闻 | 多媒体 | 研究

Zenotech Laboratories Limited 公司资料

Zenotech Laboratories Limited (Zenotech) is an India-based company that is principally engaged in the manufacture and trading of pharmaceuticals. The Company has launched 15 generic chemical oncology and anesthesiology products in India. Zenotech has three biological products: recombinant human granulocyte macrophage-colony stimulating factor (GM-CSF), recombinant human granulocyte colony stimulating factor (G-CSF) and interlukin-2 (IL-2). All the three are used in the cancer therapy area. The Company’s wholly owned subsidiaries include Zenotech Farmaceutica Do Brasil Limitada, Zenotech Laboratories Nigeria Limited and Zenotech Inc. On May 31, 2007, the Company incorporated a wholly owned subsidiary Hemarus Biologicals Limited.

公司详细信息

	主要部门	医疗-制药

	支柱产业	生物科技

	主页	www.zenotechlabs.com

Key Developments: Zenotech Laboratories Limited

	1月22日澳洲股市：卖空禁令助市 JAN 22, 2009 13:00 - 文章点击: 10,111 因为市场对全球银行业的担忧被再度引发，昨天澳洲股市在金融股的拖累下收低。基本指数S&P/ASX200下跌1%，或33.8点，报3442.8点，综合指数下跌0.9%，或30.2点，报3394.8点。监管机构澳大利亚证券投资委员会决定延长禁止进行有担保的金融债券卖空交易的期限，或将给银行业带来积极推动。